Important therapeutic approaches for re-establishing immunosurveillance comprise adaptive regulation of chemokines and cytokines contributing to immune escape, metabolic reprogramming of T cell function, up-regulation of tumor suppressor genes, e.g., Phosphatase And Tensin Homolog (PTEN), enhancing antigenicity of cancer cells (73, 75–80). This evidence concerns the gene PTEN and neoplasm.